Take the quiz Complete a 2 minute health assessment to get pre-approved for treatment instantly
Current evidence suggests these medications lead predominantly to fat loss, but some lean mass loss may occur during weight reduction, particularly if patients are eating too little overall or not consuming enough protein
Have your healthcare provider print it out on their letterhead, and then bring the letter to your HR benefits manager at workthat person may be able to contact your insurance plan on your behalf
What sets Retatrutide apart is its unique ability to engage three receptors simultaneously: GIP (Gastric Inhibitory Polypeptide) receptor GLP-1 (Glucagon-Like Peptide-1) receptor GCG (Glucagon) receptor This puts Retatrutide into a new medication class known as triple agonists
Krog-Mikkelsen I, Sloth B, Dimitrov D, Tetens I, Bjrck I, Flint A, et al